Clinical Trial: Correlation between Adverse Reactions of Atomoxetine in the Treatment of Attention Deficit Hyperactivity Disorder and Gut Microbiota (China)

Posted On: 2026-09-23

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation between Adverse Reactions of Atomoxetine in the Treatment of Attention Deficit Hyperactivity Disorder and Gut Microbiota'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133139

Registration Time: 2026/09/22

Type: Observational study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=311534

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Correlation between Adverse Reactions of Atomoxetine in the Treatment of Attention Deficit Hyperactivity Disorder and Gut Microbiota (China)